|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 31/285 | (2013.01) | ||
| A61K 31/455 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/06 | (2006.01) | ||
| A61K 31/455 | (2013.01) | ||
| A61K 31/285 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 31/60 | (2006.01) | ||
| A61K 31/60 | (2013.01) |
| (11) | Patento numeris | 3388111 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18174817.9 |
| Europos patento paraiškos padavimo data | 2009-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 189511 P | 2008-08-20 | US |
| (72) |
SCHWARTZ, Brian, Eric , US
LEWIS, Jonathan , US
KOMARNITSKY, Philip, B. , US
|
| (73) |
Solasia Pharma K.K. ,
4F, Sumitomo Fudosan Shiba-koen Tower
2-11-1 Shiba-koen
Minato-ku, Tokyo 105-0011,
JP
|
| (54) | ORGANOARSENIC COMPOUND FOR THE TREATMENT OF CANCER |
| ORGANOARSENIC COMPOUND FOR THE TREATMENT OF CANCER |